<DOC>
	<DOCNO>NCT02435290</DOCNO>
	<brief_summary>It cross-sectional study examine random sample in- out-patients , proven malignant disease receive chemotherapy , period 6 month start study visit Oncology department , Ain Shams University Teaching Hospitals . The effect risk factor prescribe error study ; risk factor include follow : Tumor type , Cancer stage , type comorbid illness , type medication , type anti-cancer treatment , number abnormal lab data , type abnormal lab data , number drug treatment regimen , number side effect chemotherapy administration , age patient , dose frequency anticancer , route administration . Summary statistic perform describe patient characteristic , frequency , type classification medication error ; frequency Medication error occur . Logistic regression apply collect data perform predictive relation risk factor may ( categorical , continuous , discrete ) prescribe error ( categorical ) .</brief_summary>
	<brief_title>Enhancement Prediction Chemotherapy Prescribing Errors Oncology Patients</brief_title>
	<detailed_description>This study perform accord hospital 's ethic board . Data age , cancer diagnosis , cancer stage , comorbid illness , detail anticancer treatment , drug comorbid illness well laboratory abnormality collected.The data collect medical record review.Progress note change make patient ' medication order since admission review . Drugs classify either `` active agent '' ( defined medication treat cancer- and/or therapy-related symptom ) `` medication treat comorbid condition . '' A comorbid illness define non-cancer clinical condition require pharmacologic treatment . Prescribing error classify : - Incorrect Medication : Medication order appropriate patient base indication , patient-specific variable , clinical status . - Medication Omission Error : patient indication treatment inadequate treatment prescribed . - Dose error : Under dosage 5 % antineoplastic drug . - Dose omission : unspecified dosage medication . - Incorrect Treatment Duration : Medication prescribe without appropriate stop time . - Potential drug-drug interaction : modification effect drug administer another drug . - Duplicate prescribing : two drug class prescribe treat condition , different condition . - Omitted improper route administration : unspecified route , wrong route , improper route patient clinical status . - Improper medication infusion rate : wrong infusion rate medication administrate via intravenous route . The prescribing error identify utilizing : 1 . Clinical Oncology guideline Ain sham university hospital . 2 . BC cancer agency ( BCCA ) cancer drug manual 3 . .the web site chemocalculator ( use identify error dose calculation ) . 4- .Drugs.com ( use identify drug-drug interaction , route administration error , dose error , infusion rate error ) . 5 -- Manual search chemotherapy prescribe error article via pubmed. , science direct . Prescribing error scheme 3 level accord scientific evidence . 1 . Established : error confirm large clinical trial . 2 . Probable : error high likelihood occurrence without definitive randomized clinical trial . 3 . Suspect : error likely occur ; data derive case report . To confirm scientific evidence error , investigator need search BC Cancer Agency , pubmed , science direct , medical journal literature ensure scientific evidence error . Reporting medication error scientific evidence 1 3 physician via e-mail . Ranking severity prescribe error , major , potential error could lead permanent damage risk death ; moderate , clinical consequence error require medical treatment ; minor , small clinical effect expect error . Clinical pharmacist discus study effect follow risk factor prescribe error : - The tumor type ( breast cancer , lymphoma myeloma , lung cancer , genitourinary cancer , gynecological cancer , GIT cancer , melanoma , head neck cancer ) . - Cancer stage . 1. early : indicate Carcinoma situ 2. : locally- advanced : indicate extensive disease : Larger tumor size and/or spread cancer beyond organ first develop nearby lymph node and/or tissue organ adjacent location primary tumor 3. metastatic : indicate The cancer spread distant tissue organ . - Type comorbid illness ( heart disease /renal disease /hepatic disease /diabetes/ hypertension / gastric disease/ blood abnormality/ osteoporosis ) . - The number drug treatment regimen . - Type medication ( active agent , comorbid illness medication ) - Type anticancer treatment - The route administration chemotherapy ( intravenous , intramuscular , Oral , Intrathecal ) . - Dosing Frequency treatment . - The number side effect chemotherapy administrate experienced patient . - The number abnormal lab data . - The type abnormal lab data ( kidney function test , liver function test , blood test ) . - The age patient . Summary statistic data perform determine incidence prescribe error oncology department Ain sham university hospital . Logistic regression analysis data perform use SPSS . - Dependent variable presence absence prescribe error reasonable supportive evidence ( i.e. , scientific evidence level 1 - 3 ) . - Explanatory variable ( risk factor ) age , cancer type , cancer stage , treatment type , type comorbid illness , number drug , type medication , number laboratory abnormality , type lab abnormality route administration , frequency treatment . Logistic regression use model determinant predict likelihood prescribing error oncology department , Ain sham university hospital . The impact ( coefficient ) risk factor quantitatively correlate prescribing error . Charts perform inform physician prescribe error high incidence , well , risk factor increase likelihood prescribing error .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>outpatient , proven malignant disease receive chemotherapy Patients receive experimental agent patient ill unwilling participate exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>prediction</keyword>
	<keyword>prescribe error</keyword>
	<keyword>risk factor</keyword>
</DOC>